BE678863A - - Google Patents
Info
- Publication number
- BE678863A BE678863A BE678863DA BE678863A BE 678863 A BE678863 A BE 678863A BE 678863D A BE678863D A BE 678863DA BE 678863 A BE678863 A BE 678863A
- Authority
- BE
- Belgium
- Prior art keywords
- product
- ethanol
- thymus
- filtrate
- evaporation
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 61
- 239000000047 product Substances 0.000 claims description 49
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 26
- 210000001541 thymus gland Anatomy 0.000 claims description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 239000000706 filtrate Substances 0.000 claims description 21
- 230000003054 hormonal effect Effects 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000003208 petroleum Substances 0.000 claims description 8
- 238000000746 purification Methods 0.000 claims description 6
- 201000004193 respiratory failure Diseases 0.000 claims description 6
- 125000000539 amino acid group Chemical group 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 238000002844 melting Methods 0.000 claims description 5
- 230000008018 melting Effects 0.000 claims description 5
- 229910052753 mercury Inorganic materials 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 4
- 208000004756 Respiratory Insufficiency Diseases 0.000 claims description 4
- 230000001684 chronic effect Effects 0.000 claims description 4
- 206010009126 Chronic respiratory failure Diseases 0.000 claims description 2
- 239000000287 crude extract Substances 0.000 claims description 2
- 239000012043 crude product Substances 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims 12
- 230000008020 evaporation Effects 0.000 claims 11
- 238000011084 recovery Methods 0.000 claims 10
- 239000000284 extract Substances 0.000 claims 8
- 235000019483 Peanut oil Nutrition 0.000 claims 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 4
- 238000002803 maceration Methods 0.000 claims 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims 4
- 239000000312 peanut oil Substances 0.000 claims 4
- 230000001747 exhibiting effect Effects 0.000 claims 3
- 238000004090 dissolution Methods 0.000 claims 2
- 238000012360 testing method Methods 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 241000700159 Rattus Species 0.000 description 5
- 244000309466 calf Species 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000009194 climbing Effects 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- SQQCWHCJRWYRLB-UHFFFAOYSA-N 2,3,4,5,6-pentahydroxy-1-[4-[4-[(2,3,4,5,6-pentahydroxy-1-sulfohexyl)amino]phenyl]sulfonylanilino]hexane-1-sulfonic acid Chemical compound C1=CC(NC(C(O)C(O)C(O)C(O)CO)S(O)(=O)=O)=CC=C1S(=O)(=O)C1=CC=C(NC(C(O)C(O)C(O)C(O)CO)S(O)(=O)=O)C=C1 SQQCWHCJRWYRLB-UHFFFAOYSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 241001553178 Arachis glabrata Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001111317 Chondrodendron tomentosum Species 0.000 description 1
- 241001503987 Clematis vitalba Species 0.000 description 1
- 206010020591 Hypercapnia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- -1 aliphatic primary amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000009661 fatigue test Methods 0.000 description 1
- 230000009760 functional impairment Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- XXPDBLUZJRXNNZ-UHFFFAOYSA-N promethazine hydrochloride Chemical compound Cl.C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 XXPDBLUZJRXNNZ-UHFFFAOYSA-N 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 230000007666 subchronic toxicity Effects 0.000 description 1
- 231100000195 subchronic toxicity Toxicity 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 125000001302 tertiary amino group Chemical class 0.000 description 1
- 229940034252 thymus extracts Drugs 0.000 description 1
- 239000000724 thymus hormone Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002061 vacuum sublimation Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE678863 | 1966-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE678863A true BE678863A (d) | 1966-09-16 |
Family
ID=3848430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE678863D BE678863A (d) | 1966-04-01 | 1966-04-01 |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE678863A (d) |
-
1966
- 1966-04-01 BE BE678863D patent/BE678863A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1373176B1 (fr) | Extrait de coques de graines de lupin contenant du lupeol | |
| WO2018197731A1 (fr) | Extrait de 20-hydroxyecdysone de qualité pharmaceutique, son utilisation et sa préparation | |
| FR2964570A1 (fr) | Procede de preparation d'un extrait de centella asiatica | |
| FR2518406A1 (fr) | Nouveau procede d'obtention de substances vaso-actives extraites de feuilles de ginkgo | |
| BE678863A (d) | ||
| FR2470762A1 (fr) | Procede de traitement d'un residu de production d'acide adipique | |
| EP0012640B1 (fr) | Procédé de purification de l'acide chénodésoxycholique et produits obtenus par ce procédé | |
| Ramage et al. | 122. The caryophyllenes. Part II | |
| EP0089894A1 (fr) | (Benzimidazolyl-1)-1,N-((hydroxy-4 méthoxy-3 phényl)-2 hydroxy-2 éthyl) amino-3 butane et ses sels et hydrates à activité bêta-adrénergique, leurs applications thérapeutiques, et procédé pour les préparer | |
| JP2002536533A (ja) | 揮発性油の抽出 | |
| FR2519253A1 (fr) | Procede pour isoler des composes a effet laxatif du sene medicinal, ces composes et leurs utilisations therapeutiques | |
| BE818380A (fr) | Methode pour l'extraction simple de la cinobufagine du bufonis venenum brut | |
| CH401088A (fr) | Procédé d'obtention du 1-rhamnoside de 6-méthyl-1,3,8-trihydroxyanthraquinone par extraction conditionnée de Rhamnacées | |
| JPH0694434B2 (ja) | １０−ヒドロキシ−δ−２−デセン酸の製法 | |
| FR2653999A1 (fr) | Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant. | |
| CH332662A (fr) | Procédé de préparation d'émétine | |
| BE416160A (d) | ||
| BE532575A (d) | ||
| WO2008061984A2 (fr) | Procede d'extraction d'aloine | |
| CH414945A (fr) | Procédé d'obtention de galantamine pure à partir de plantes de la famille des " Amaryllidaceae " | |
| BE476705A (d) | ||
| BE684858A (d) | ||
| WO1995009861A1 (fr) | Procede de cristallisation du lactulose | |
| JPH06247893A (ja) | オクタデカテトラエン酸の製造方法 | |
| BE563714A (d) |